Pharmacodynamic Foundations
1. Autonomic Nervous System Receptors & Dynamics
Understanding cardiovascular pharmacology begins with the autonomic nervous system (ANS). The sympathetic (adrenergic) and parasympathetic (cholinergic) divisions regulate heart rate, vascular tone, and myocardial contractility.
Adrenergic Receptors (Sympathetic)
- Alpha-1 ($\alpha_1$): Located in vascular smooth muscle. Stimulation causes vasoconstriction and increased blood pressure. Inhibitors (Alpha-blockers, e.g., doxazosin) cause vasodilation.
- Beta-1 ($\beta_1$): Located primarily in the myocardium. Stimulation increases heart rate (chronotropy), contractility (inotropy), and AV node conduction (dromotropy). "1 Heart".
- Beta-2 ($\beta_2$): Located in bronchial smooth muscle and coronary vessels. Stimulation causes bronchodilation and mild vasodilation. "2 Lungs".
Cholinergic Receptors (Parasympathetic)
- Muscarinic Receptors: Activated by acetylcholine (ACh) via the vagus nerve. Stimulation slows heart rate and AV conduction.
- Anticholinergics (e.g., Atropine): Block muscarinic actions, increasing heart rate. Used as a first-line agent for symptomatic sinus bradycardia.
Major Antihypertensive Classes
2. Antihypertensive Pharmacology & Nursing Rules
Antihypertensives modify systemic vascular resistance, fluid volume, or cardiac output to lower blood pressure.
| Drug Class & Suffix |
Prototypes |
Mechanism of Action |
Key Adverse Effects & Nursing Rules |
| ACE Inhibitors (-pril) |
Lisinopril, Enalapril, Captopril |
Blocks conversion of Angiotensin I to Angiotensin II, causing vasodilation and reduced aldosterone. |
Dry persistent cough, hyperkalemia, angioedema (airway emergency). Contraindicated in pregnancy. |
| ARBs (-sartan) |
Losartan, Valsartan |
Blocks Angiotensin II receptors directly; does not affect bradykinin (no cough). |
Hyperkalemia, dizziness. Used as an alternative when ACE inhibitors cause cough. Contraindicated in pregnancy. |
| Beta-Blockers (-olol) |
Metoprolol, Atenolol, Propranolol |
Blocks $\beta_1$ (and non-selective $\beta_2$) receptors, decreasing HR and contractility. |
Bradycardia, hypotension, fatigue. Check HR and BP prior; hold if HR < 60 bpm or SBP < 100. Non-selective BBs (propranolol) cause bronchospasm (avoid in asthma/COPD). Mask hypoglycemia symptoms. |
| Calcium Channel Blockers (-dipine / non-dihydropyridines) |
Amlodipine, Nifedipine, Diltiazem, Verapamil |
Inhibits calcium entry into vascular smooth muscle and cardiac cells, causing arterial vasodilation and slowed AV conduction. |
Peripheral edema, bradycardia (diltiazem/verapamil), constipation. Avoid grapefruit juice (increases drug toxicity). |
Cardiac Glycosides
3. Digoxin Safety Protocol & Toxicity Management
Digoxin is a cardiac glycoside used in heart failure and atrial fibrillation. It exerts a positive inotropic effect (increases myocardial contractility) and a negative chronotropic effect (decreases heart rate).
Essential Digoxin Safety Guidelines
- Apical Pulse Check: Assess the apical pulse for 1 full minute prior to administration. Hold Digoxin and notify the provider if apical pulse is < 60 bpm in adults, < 70 bpm in children, or < 90 bpm in infants.
- Therapeutic Serum Level: Narrow therapeutic index ($0.5\text{--}2.0\text{ ng/mL}$). Levels $> 2.0\text{ ng/mL}$ indicate toxicity.
- Hypokalemia Warning: Serum potassium levels below $3.5\text{ mEq/L}$ significantly increase the risk of Digoxin toxicity because low potassium allows greater binding of Digoxin to myocardium. Always check serum potassium before giving Digoxin.
- Signs of Digoxin Toxicity: Early: Anorexia, nausea, vomiting, fatigue, headache. Late/Classic: Visual disturbances (yellow-green halos around lights, blurred vision) and cardiac dysrhythmias (bradycardia, AV block).
- Antidote: Digoxin Immune Fab (Digibind).
Renal & Vascular Fluid Management
4. Diuretic Classifications & Electrolyte Monitoring
Diuretics promote renal sodium and water excretion to reduce intravascular fluid volume in heart failure, hypertension, and edema.
Loop Diuretics (e.g., Furosemide, Bumetanide)
Inhibits $\text{Na}^+/\text{K}^+/2\text{Cl}^-$ cotransport in the thick ascending Loop of Henle. Potent diuretic effect.
- Adverse Effects: Hypokalemia, hyponatremia, dehydration, hypotension, hyperuricemia (gout), and ototoxicity (if IV push is administered too rapidly).
- Nursing Care: Monitor serum potassium, encourage potassium-rich foods (bananas, oranges, spinach), administer IV push slowly ($20\text{ mg/min}$).
Potassium-Sparing Diuretics (e.g., Spironolactone)
Competitively blocks aldosterone receptors in distal tubules, promoting sodium excretion while retaining potassium.
- Adverse Effects: Hyperkalemia ($\text{K}^+ > 5.0\text{ mEq/L}$), gynecomastia (menstrual irregularities).
- Nursing Care: Monitor serum potassium closely; educate clients to avoid potassium supplements and salt substitutes (which contain potassium chloride).
Antithrombotic Therapy
5. Anticoagulants, Antiplatelets & Thrombolytics
Antithrombotic agents prevent or dissolve blood clots in deep vein thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, and atrial fibrillation.
1. Heparin (Unfractionated) vs. Enoxaparin (LMWH)
Unfractionated Heparin (IV/SubQ): Inhibits thrombin and Factor Xa. Requires continuous monitoring of aPTT (therapeutic target: 1.5–2.5 times baseline, typically 60–80 seconds). Watch for Heparin-Induced Thrombocytopenia (HIT) (sudden $\ge 50\%$ drop in platelet count). Antidote: Protamine Sulfate.
Low Molecular Weight Heparin (Enoxaparin): Given SubQ in abdominal tissue (do not expel air bubble in prefilled syringe; do not rub site). Fixed dosing; routine aPTT monitoring not required.
2. Warfarin (Oral Anticoagulant)
Inhibits Vitamin K-dependent clotting factors (II, VII, IX, X). Monitored via PT / INR (therapeutic INR range: 2.0–3.0 for most conditions; 2.5–3.5 for mechanical heart valves). Educate clients to maintain consistent dietary Vitamin K intake (green leafy vegetables). Antidote: Vitamin K (Phytonadione).
3. Thrombolytics (e.g., Alteplase / tPA)
Directly converts plasminogen to plasmin, dissolving existing fibrin clots ("clot busters"). Used in acute ischemic stroke, massive PE, and STEMI. Strict Contraindications: Active internal bleeding, history of hemorrhagic stroke, recent major surgery or trauma (< 3 weeks), severe uncontrolled hypertension ($\text{BP} > 185/110\text{ mmHg}$).
NCLEX / ATI Board Style Question
Clinical Practice Drill
Domain: Cardiac Pharmacology / Safety
Question: A nurse is preparing to administer daily oral Digoxin $0.125\text{ mg}$ to a client with heart failure. Which of the following laboratory results should cause the nurse to hold the medication and immediately contact the healthcare provider?
A) Serum sodium level of $138\text{ mEq/L}$
Option A
B) Serum potassium level of $3.1\text{ mEq/L}$
Correct Answer ✓
C) Serum calcium level of $9.5\text{ mg/dL}$
Option C
D) Serum Digoxin level of $1.1\text{ ng/mL}$
Option D
Clinical Rationale:
Correct Answer: B (Serum potassium level of $3.1\text{ mEq/L}$). Hypokalemia (serum potassium $< 3.5\text{ mEq/L}$) significantly increases the risk of Digoxin toxicity because low extracellular potassium enhances Digoxin binding to the $\text{Na}^+/\text{K}^+$ ATPase pump on cardiac cells. The nurse must hold Digoxin and notify the provider to correct potassium levels before administration.
Distractor Analysis: Serum sodium $138\text{ mEq/L}$ (Option A) and calcium $9.5\text{ mg/dL}$ (Option C) are within normal reference ranges. A Digoxin level of $1.1\text{ ng/mL}$ (Option D) is within the therapeutic range ($0.5\text{--}2.0\text{ ng/mL}$).
Frequently Asked Questions
High-Intent Pharmacology Queries
Why do ACE inhibitors cause a dry cough, while ARBs do not?
ACE inhibitors block Angiotensin-Converting Enzyme, which is also responsible for breaking down bradykinin in the lungs. Accumulation of bradykinin triggers a dry, persistent cough. ARBs block Angiotensin II receptors directly and do not prevent bradykinin breakdown, avoiding the cough.
What are the antidotes for Heparin and Warfarin toxicity?
The reversal agent for Unfractionated Heparin is Protamine Sulfate. The reversal agent for Warfarin is Vitamin K (Phytonadione) or Fresh Frozen Plasma (FFP) for emergency reversal.
